Search

Memorial Sloan Kettering Cancer Center (MSK) announces the return of NYC for MSK to celebrate MSK’s 141st anniversary.

… Tuesday, June 3, 2025 Memorial Sloan Kettering Cancer Center (MSK) announces the return of  NYC for MSK  to celebrate MSK’s 141st anniversary. For one day, New York City’s most notable brands in fashion, food, toys, and sports will come together to support MSK’s mission of ending cancer for life. On

A new study led by MSK investigators reveals how some cancer cells become resistant to targeted treatment and suggests what might be done to stop that from happening.

… Thursday, April 9, 2015 Summary Most cancers treated with targeted therapy ultimately become resistant to treatment, stop shrinking, and eventually progress. New research led by investigators at Memorial Sloan Kettering shows how melanoma and lung cancer cells that initially respond to targeted therapies

Chemotherapy is among the most commonly prescribed, and commonly misunderstood, cancer treatments. It’s time to revise what you thought you knew.

… Tuesday, August 30, 2016 Summary Chemotherapy drugs have evolved considerably over the years. Now, we can treat patients with little to no interference in their everyday lives. We have made great strides in treating cancer with chemotherapy drugs, yet myths about these medications still remain. Donna

Meet Cancer Engineering MD-PhD candidate Brandon Cuevas: “Being able to be a bridge between medicine and research is such a privilege, one that not many places can offer.”

… Friday, June 6, 2025 Brandon Cuevas was just a sophomore in high school when he set his sights on becoming a physician-scientist at Memorial Sloan Kettering Cancer Center (MSK). “My aunt was diagnosed with stage 3 breast cancer,” says Brandon, who grew up in and around New York City. “It was the first

Dr. Hedvig Hricak is leading an international commission calling for a global strategy on improving access to more effective cancer care.

… Thursday, March 4, 2021 An international Commission of nuclear medicine and medical imaging experts led by Dr. Hedvig Hricak , Chair of Memorial Sloan Kettering’s Department of Radiology, recently released data from the first ever report that quantified imaging and nuclear medicine resources worldwide

During meiosis, small chromosomes risk being lost in the shuffle. Here’s how they hold their own.

… Wednesday, May 6, 2020 Summary Scientists at the Sloan Kettering Institute have solved the puzzle of how small chromosomes ensure that they aren’t skipped over during meiosis, the process that makes sperm and egg. From avocado plants to baker’s yeast, humans to zebras, sexually reproducing organisms

A new pancreatic cancer research center has been created at Memorial Sloan Kettering Cancer Center (MSKCC). The ambitious initiative was established with an initial commitment of $10 million from MSKCC Board member David M. Rubenstein.

… Friday, December 7, 2012 A new pancreatic cancer research center has been created at Memorial Sloan Kettering Cancer Center (MSKCC).  The ambitious initiative was established with an initial commitment of $10 million from MSKCC Board member David M. Rubenstein. The new program, called the David M. Rubenstein

As construction began on the Mortimer B. Zuckerman Research Center, SKI adopted new ways to advance therapeutic innovation at Memorial Sloan Kettering.

… Saturday, January 1, 2011 Summary As construction began on the Mortimer B. Zuckerman Research Center, SKI adopted new ways to advance therapeutic innovation at Memorial Sloan Kettering. As construction began on a new research facility, now named the Mortimer B. Zuckerman Research Center , Sloan Kettering

Nearly every advance in cancer care today is possible because of clinical trials. MSK is breaking down the age barrier that has made it hard for young patients such as Irving Romero Torres to participate in and benefit from clinical research.

… Friday, October 1, 2021 When Irving Romero Torres learned that the cancer he’d been battling for three years had come back, he was “scared, really scared.” But he wasn’t defeated. “I didn’t hesitate to go back on treatment,” he says. “I was ready to fight again.” Pediatric oncologist Emily Slotkin Pediatric

For HER2-positive breast cancers, MRI scans that employ machine-learning algorithms can provide more guidance than biopsies alone.

… Friday, October 23, 2020 Summary For breast cancers that have high levels of HER2, advanced MRI scans and artificial intelligence may help doctors make treatment decisions. For people with breast cancer , biopsies have long been the gold standard for characterizing the molecular changes in a tumor, which